gadicke造句

• But Gadicke doesn't see either hub dominating in the future.
• The East Coast is also more accessible to European biotech companies, an increasingly important consideration, Gadicke said.
• The growth of new companies has picked up in New England, Gadicke said, and the region is catching up to the Bay Area.
• Gadicke, sees big opportunities ahead in biotech, particularly weekly scientific breakthroughs in genomics, the study of genes that cause diseases and other areas.
• Knowing whether the proposed drug will work and forecast its chances of gaining US Food and Drug Adminstration approval sharply reduces the financial risks, Gadicke said.
• Ansbert K . Gadicke, founding partner of MPM, said that biotech companies in the past might have gone public with drugs in early stages of development.
• "Biotechnology in the next 20 years will provide us with new drugs to treat the underlying causes of diabetes, and certain cancers and cardiovascular diseases, " said Gadicke.
• Tapping European money sources, MPM Capital's president, Dr . Ansbert Gadicke, quickly raised $ 230 million for his Cambridge-based firm, which has invested in 25 companies in less than three years.
• Dr . Ansbert Gadicke, general partner and chairman of MPM Capital, said he expects to see Massachusetts and San Francisco on an equal footing in the future, laying claim to even bigger portions of the nation's biotech industry.
• Gadicke and MPM are putting more money into companies _ an average of $ 15 million per company in the new $ 600 million fund spread out over three to five years, versus an average of $ 8 million in the current fund.
• "I think there will be more biotech money raised in the near-term as investors see the opportunities in genomics, bioinformatics, and other scientific areas but it will always be a small part next to high tech investing, " said Gadicke, who previously worked at Boston Consulting Group developing business strategies and product marketing development with pharmaceutical companies firms as well as his own company.